Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Coupland N. J., Bell C. J., Potokar J. P. Serotonin reuptake inhibitor withdrawal. J Clin Psychopharmacol. 1996 Oct;16(5):356–362. doi: 10.1097/00004714-199610000-00003. [DOI] [PubMed] [Google Scholar]
- Faherty C. J., Earley B., Leonard B. E. Behavioural effects of selective serotonin reuptake inhibitors following direct micro injection into the left red nucleus of the rat. J Psychopharmacol. 1997;11(1):53–58. doi: 10.1177/026988119701100114. [DOI] [PubMed] [Google Scholar]
- Farah A., Lauer T. E. Possible venlafaxine withdrawal syndrome. Am J Psychiatry. 1996 Apr;153(4):576–576. doi: 10.1176/ajp.153.4.576a. [DOI] [PubMed] [Google Scholar]
- Holliday S. M., Benfield P. Venlafaxine. A review of its pharmacology and therapeutic potential in depression. Drugs. 1995 Feb;49(2):280–294. doi: 10.2165/00003495-199549020-00010. [DOI] [PubMed] [Google Scholar]
- Leo R. J. Movement disorders associated with the serotonin selective reuptake inhibitors. J Clin Psychiatry. 1996 Oct;57(10):449–454. doi: 10.4088/jcp.v57n1002. [DOI] [PubMed] [Google Scholar]
- Lieberman J. A., Kane J. M., Reife R. Neuromuscular effects of monoamine oxidase inhibitors. Adv Neurol. 1986;43:231–249. [PubMed] [Google Scholar]